Search

Showing "11154" results for ""

Undetectable viral load associated with unprotected sex amongst HIV discordant gay couples in Sydney

Lowest-ever CD4 cell count can predict how long treatment can be interrupted

Risk of resistance with nevirapine-containing HAART after pregnancy, even when stopped correctly

Latvian study reports good responses to individualised, directly observed therapy in patients with multidrug resistant tuberculosis

Does GB virus C protect against HIV disease progression?

Cotrimoxazole prophylaxis reduces the risk of death in TB patients

Tenofovir / FTC 'non-inferior' to Combivir after one year, Gilead study shows (corrected)

LGV spreading throughout Western Europe, 2 cases in New York

‘Action required’ in response to increase in HIV and other STIs in Northern Ireland

Elevated insulin associated with buffalo hump in Australian study

Most children thriving after four years of HAART

Pegasys approved in Europe for treatment of HCV in HIV/HCV coinfected patients

Roche issues warning about use of boosted saquinavir with rifampicin

Infection associated with elevated lipids in HAART-naive HIV-positive patients

CD4-guided structured treatment interruptions safe in patients at high risk of resistance

Protease inhibitors associated with increased risk of cardiovascular disease

HIV/AIDS deaths in South Africa are substantially underreported

Routine HIV testing clinically and economically justified, and would cut spread of HIV, say US researchers

Receive the latest HIV research and conference news

Showing "11154" results for ""

Undetectable viral load associated with unprotected sex amongst HIV discordant gay couples in Sydney

Lowest-ever CD4 cell count can predict how long treatment can be interrupted

Risk of resistance with nevirapine-containing HAART after pregnancy, even when stopped correctly

Latvian study reports good responses to individualised, directly observed therapy in patients with multidrug resistant tuberculosis

Does GB virus C protect against HIV disease progression?

Cotrimoxazole prophylaxis reduces the risk of death in TB patients

Tenofovir / FTC 'non-inferior' to Combivir after one year, Gilead study shows (corrected)

LGV spreading throughout Western Europe, 2 cases in New York

‘Action required’ in response to increase in HIV and other STIs in Northern Ireland

Elevated insulin associated with buffalo hump in Australian study

Most children thriving after four years of HAART

Pegasys approved in Europe for treatment of HCV in HIV/HCV coinfected patients

Roche issues warning about use of boosted saquinavir with rifampicin

Infection associated with elevated lipids in HAART-naive HIV-positive patients

CD4-guided structured treatment interruptions safe in patients at high risk of resistance

Protease inhibitors associated with increased risk of cardiovascular disease

HIV/AIDS deaths in South Africa are substantially underreported

Routine HIV testing clinically and economically justified, and would cut spread of HIV, say US researchers

Receive the latest HIV research and conference news